(Q51817173)
Statements
An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris. (English)
1 reference
pemphigus vulgaris
1 reference
D F Arnold
1 reference
J Burton
1 reference
B Shine
1 reference
F Wojnarowska
1 reference
S A Misbah
1 reference
16 February 2009
1 reference
160
1 reference
5
1 reference
1098-1102
1 reference